Zhejiang Hisoar Pharmaceutical Co Ltd (002099) — Cash Flow Reinvestment Rate
Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Cash Flow Reinvestment Rate of 1.07x as of September 2025, reinvesting CN¥16.52 Million (capex CN¥16.52 Million ) from operating cash flow of CN¥15.48 Million. Check Zhejiang Hisoar Pharmaceutical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Zhejiang Hisoar Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2004–2024)
Historical reinvestment intensity for Zhejiang Hisoar Pharmaceutical Co Ltd across 21 annual periods. Explore 002099 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Zhejiang Hisoar Pharmaceutical Co Ltd (2004–2024)
Year-by-year capital reinvestment analysis for Zhejiang Hisoar Pharmaceutical Co Ltd. For live market cap and broader valuation context, see 002099 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.84x | CN¥146.11 Million | CN¥174.83 Million | CN¥122.11 Million | ▲ +10.7% |
| 2023 | 0.76x | CN¥181.63 Million | CN¥240.54 Million | CN¥153.08 Million | ▼ -86.3% |
| 2022 | 5.50x | CN¥638.56 Million | CN¥116.09 Million | CN¥179.42 Million | ▲ +16.4% |
| 2021 | 4.72x | CN¥483.56 Million | CN¥102.36 Million | CN¥229.56 Million | ▲ +3294.3% |
| 2020 | 0.14x | CN¥74.30 Million | CN¥533.87 Million | CN¥74.18 Million | ▼ -91.8% |
| 2019 | 1.70x | CN¥1.04 Billion | CN¥612.40 Million | CN¥160.64 Million | ▲ +21.6% |
| 2018 | 1.40x | CN¥1.11 Billion | CN¥791.45 Million | CN¥255.78 Million | ▼ -38.4% |
| 2017 | 2.27x | CN¥232.73 Million | CN¥102.68 Million | CN¥148.99 Million | ▲ +385.4% |
| 2016 | 0.47x | CN¥293.90 Million | CN¥629.42 Million | CN¥124.31 Million | ▼ -53.7% |
| 2015 | 1.01x | CN¥465.94 Million | CN¥462.16 Million | CN¥296.36 Million | ▲ +14.2% |
| 2014 | 0.88x | CN¥169.06 Million | CN¥191.56 Million | CN¥169.06 Million | ▼ -80.9% |
| 2013 | 4.63x | CN¥281.79 Million | CN¥60.85 Million | CN¥281.79 Million | ▲ +96.1% |
| 2012 | 2.36x | CN¥426.79 Million | CN¥180.73 Million | CN¥426.79 Million | ▲ +0.5% |
| 2011 | 2.35x | CN¥217.52 Million | CN¥92.62 Million | CN¥217.52 Million | ▲ +190.0% |
| 2010 | 0.81x | CN¥146.51 Million | CN¥180.88 Million | CN¥146.51 Million | ▲ +48.7% |
| 2009 | 0.54x | CN¥53.60 Million | CN¥98.38 Million | CN¥53.60 Million | ▼ -81.6% |
| 2008 | 2.95x | CN¥90.40 Million | CN¥30.61 Million | CN¥90.40 Million | ▲ +34.1% |
| 2007 | 2.20x | CN¥112.61 Million | CN¥51.14 Million | CN¥112.61 Million | ▲ +32.8% |
| 2006 | 1.66x | CN¥102.59 Million | CN¥61.88 Million | CN¥102.59 Million | ▼ -18.9% |
| 2005 | 2.04x | CN¥73.74 Million | CN¥36.07 Million | CN¥73.74 Million | ▲ +103.6% |
| 2004 | 1.00x | CN¥42.54 Million | CN¥42.36 Million | CN¥42.54 Million | — |